| Technical and biological review of authorized medical devices for platelets-rich plasma preparation in the field of regenerative medicine J Magalon, T Brandin, P Francois, C Degioanni, L De Maria, F Grimaud, ... Platelets 32 (2), 200-208, 2021 | 45 | 2021 |
| A retrospective analysis of characteristic features of responders and impaired patients to a single injection of pure platelet-rich plasma in knee osteoarthritis C Bec, A Rousset, T Brandin, P François, S Rabarimeriarijaona, ... Journal of Clinical Medicine 10 (8), 1748, 2021 | 9 | 2021 |
| Response to Universal Classification System for Platelet-Rich Plasma (PRP): A Method to define the variables in PRP production. J Magalon, M Abellan-Lopez, T Brandin, C Degioanni, F Grimaud, ... Burns: Journal of the International Society for Burn Injuries 47 (2), 489-490, 2020 | 2 | 2020 |
| 4CPS-074 efficacy and safety of sotrovimab: results of a retrospective observational study in a French hospital T Brandin, H Capelle, J Allemand, LF Cheung, C Dumazer European Journal of Hospital Pharmacy 30 (Suppl 1), A48-A48, 2023 | 1 | 2023 |
| Contrôle qualité des préparations magistrales en officine: contraintes réglementaires et pistes d’amélioration C Curti, T Brandin, T Kabac, S Gallice, D Martin-Privat, E Lamy, P Vanelle Le Pharmacien Hospitalier et Clinicien 55 (3), 268-274, 2020 | 1 | 2020 |
| Platelet-rich plasma preparations in sports rehabilitation: Where we started and where we should go J Magalon, T Brandin, F Grimaud, S Rabarimeriarijaona, J Veran, ... Annals of physical and rehabilitation medicine 65 (4), 101414, 2022 | | 2022 |
| Stability Studies of Fludrocortisone Acetate Capsules and Fludrocortisone Acetate Titrated Powders (Powder Triturates). T Brandin, M Wasilewski, C Panuccio, C Bouguergour, N Primas, E Lamy, ... International Journal of Pharmaceutical Compounding 26 (2), 150-154, 2022 | | 2022 |
| Utilisation thérapeutique du plasma riche en plaquettes (PRP): efficacité clinique et aspects règlementaires T Brandin | | 2021 |
